NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Longboard Pharmaceuticals Inc (NASDAQ: LBPH)
LBPH Technical Analysis
5
As on 9th Jun 2023 LBPH STOCK Price closed @ 7.45 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 4.31 & Strong Buy for SHORT-TERM with Stoploss of 4.69 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LBPHSTOCK Price
Open | 7.66 | Change | Price | % |
High | 7.87 | 1 Day | -0.36 | -4.61 |
Low | 6.95 | 1 Week | 0.53 | 7.66 |
Close | 7.45 | 1 Month | 0.11 | 1.50 |
Volume | 180733 | 1 Year | 1.45 | 24.17 |
52 Week High 10.05 | 52 Week Low 2.95 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
LBPH Daily Charts |
LBPH Intraday Charts |
Whats New @ Bazaartrend |
LBPH Free Analysis |
|
LBPH Important Levels Intraday
RESISTANCE | 9.22 |
RESISTANCE | 8.65 |
RESISTANCE | 8.30 |
RESISTANCE | 7.95 |
SUPPORT | 6.95 |
SUPPORT | 6.60 |
SUPPORT | 6.25 |
SUPPORT | 5.68 |
LBPH Forecast May 2024
4th UP Forecast | 10.48 |
3rd UP Forecast | 9.51 |
2nd UP Forecast | 8.91 |
1st UP Forecast | 8.31 |
1st DOWN Forecast | 6.59 |
2nd DOWN Forecast | 5.99 |
3rd DOWN Forecast | 5.39 |
4th DOWN Forecast | 4.42 |
LBPH Weekly Forecast
4th UP Forecast | 9.86 |
3rd UP Forecast | 9.09 |
2nd UP Forecast | 8.61 |
1st UP Forecast | 8.13 |
1st DOWN Forecast | 6.77 |
2nd DOWN Forecast | 6.29 |
3rd DOWN Forecast | 5.81 |
4th DOWN Forecast | 5.04 |
LBPH Forecast2024
4th UP Forecast | 22.08 |
3rd UP Forecast | 17.39 |
2nd UP Forecast | 14.49 |
1st UP Forecast | 11.59 |
1st DOWN Forecast | 3.31 |
2nd DOWN Forecast | 0.41 |
3rd DOWN Forecast | -2.49 |
4th DOWN Forecast | -7.18 |
Longboard Pharmaceuticals Inc ( NASDAQ USA Symbol : LBPH )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LBPH Other Details
Segment | EQ | |
Market Capital | 130837040.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
LBPH Address
LBPH Latest News
LBPH Business Profile
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals, Inc. was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. The company was founded in 2020 and is based in San Diego, California. Address: 6154 Nancy Ridge Drive, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service